Behavior of immune players in the tumor microenvironment
- 1 January 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 21 (1) , 53-59
- https://doi.org/10.1097/cco.0b013e32831bc38a
Abstract
Purpose of review Tumors recruit various immune cells with seemingly contrasting functions. Yet, the precise role of these cells in situ remains vastly unknown. This review presents a new discovery effort that employs intravital imaging to study immune players directly in tissues. Recent findings Cytotoxic T lymphocytes (CTLs) that recognize cognate antigenic peptide can infiltrate tumors from the periphery to the center, and physically engage and eliminate antigen-presenting tumor cells. Nevertheless, the reported kinetics for tumor cell killing by CTLs in vivo is surprisingly low as it takes several hours for one CTL to eliminate one tumor cell. Also, T regulatory (Treg) cells can create a suppressive milieu that restricts the release of CTL cytotoxic granules, which protects tumor cells from being killed. CTLs may be further subverted during lengthy interactions with tumor-associated macrophages (TAMs). Finally, TAMs can directly facilitate tumor invasion by recruiting tumor cells nearby vessels and promoting their intravasation. Summary Intravital imaging has started to uncover tumor-related immune events as they unfold in vivo. The technology should be exploited in the coming years to dissect further the tumor microenvironment and to define therapeutics that augment antitumor immunity.Keywords
This publication has 64 references indexed in Scilit:
- Fluorescence molecular tomography resolves protease activity in vivoNature Medicine, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002
- The Immunological Synapse of CTL Contains a Secretory Domain and Membrane BridgesImmunity, 2001
- Somatic activation of the K-ras oncogene causes early onset lung cancer in miceNature, 2001
- Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to MalignancyThe Journal of Experimental Medicine, 2001
- Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T LymphocytesThe Journal of Experimental Medicine, 1998
- Tumor Induction of VEGF Promoter Activity in Stromal CellsCell, 1998
- gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide LigandThe Journal of Experimental Medicine, 1998
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991